Home LiteratureArticle Details
PMID: 17442715 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases.

Journal of virology ·Vol. 81 ·No. 13 ·2007-07-00 ·Pages 7001-10

Qian LW, Xie J, Ye F, Gao SJ

Abstract

Matrix metalloproteinases (MMPs) play important roles in cancer invasion, angiogenesis, and inflammatory infiltration. Kaposi's sarcoma is a highly disseminated angiogenic tumor of proliferative endothelial cells linked to infection by Kaposi's sarcoma-associated herpesvirus (KSHV). In this study, we showed that KSHV infection increased the invasiveness of primary human umbilical vein endothelial cells (HUVEC) in a Matrigel-based cell invasion assay. KSHV-induced cell invasion was abolished by an inhibitor of MMPs, BB-94, and occurred in both autocrine- and paracrine-dependent fashions. Analysis by zymography and Western blotting showed that KSHV-infected HUVEC cultures had increased secretion of MMP-1, -2, and -9. KSHV increased the secretion of MMP-2 within 1 h following infection without upregulating its mRNA expression level. In contrast, the secretion of MMP-1 and -9 was not increased until 6 h after KSHV infection and was correlated with the upregulation of their mRNA expression levels. Promoter analysis by reporter assays and electrophoretic mobility shift assays identified an AP-1 cis-element as the dominant KSHV-responsive site in the MMP-1 promoter. Together, these results suggest that KSHV infection modulates the production of multiple MMPs to increase cell invasiveness and thus contributes to the pathogenesis of KSHV-induced malignancies.

MeSH Terms
Autocrine Communication/drug effects Cell Transformation, Viral Cells, Cultured Collagenases/biosynthesis Endothelial Cells/enzymology,pathology,virology Gene Expression Regulation, Enzymologic/drug effects Herpesvirus 8, Human/metabolism Humans Neoplasm Invasiveness/pathology Neovascularization, Pathologic/enzymology,pathology,virology Paracrine Communication/drug effects Phenylalanine/analogs & derivatives,pharmacology Protease Inhibitors/pharmacology RNA, Messenger/biosynthesis RNA, Neoplasm/biosynthesis Response Elements Sarcoma, Kaposi/enzymology,pathology Thiophenes/pharmacology Transcription Factor AP-1/metabolism Umbilical Veins/enzymology,pathology,virology Up-Regulation/drug effects
Chemicals
Protease Inhibitors RNA, Messenger RNA, Neoplasm Thiophenes Transcription Factor AP-1 Phenylalanine batimastat Collagenases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Qian Li-Wu
Tumor Virology Program, Greehey Children's Cancer Research Institute, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Xie Jianping
Ye Fengchun
Gao Shou-Jiang
References (51)
51 references, click to expand
  1. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.
    Nat Genet. 2004 Jul;36(7):687-93 PMID: 15220918
  2. Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines.
    Int J Cancer. 2003 Jan 10;103(2):161-8 PMID: 12455029
  3. ORF36 protein kinase of Kaposi's sarcoma herpesvirus activates the c-Jun N-terminal kinase signaling pathway.
    J Biol Chem. 2004 Sep 10;279(37):38325-30 PMID: 15247271
  4. Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation.
    Virology. 2004 Oct 10;328(1):7-18 PMID: 15380353
  5. Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness.
    Cancer Res. 1991 May 15;51(10):2670-6 PMID: 2021945
  6. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.
    Science. 1994 Dec 16;266(5192):1865-9 PMID: 7997879
  7. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.
    N Engl J Med. 1996 Jul 25;335(4):233-41 PMID: 8657239
  8. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
    Nature. 1998 Jan 1;391(6662):86-9 PMID: 9422510
  9. Active and tissue inhibitor of matrix metalloproteinase-free gelatinase B accumulates within human microvascular endothelial vesicles.
    J Biol Chem. 1998 Feb 27;273(9):5400-4 PMID: 9479001
  10. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1.
    Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3621-6 PMID: 9520415
  11. Constitutive release of metalloproteinase-9 (92-kd type IV collagenase) by Kaposi's sarcoma cells.
    J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jul 1;18(3):203-9 PMID: 9665496
  12. Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins.
    Cancer Res. 2003 Jan 1;63(1):256-62 PMID: 12517806
  13. Matrix metalloproteinases process the laminin-5 gamma 2-chain and regulate epithelial cell migration.
    Biochem Biophys Res Commun. 2003 Apr 18;303(4):1012-7 PMID: 12684035
  14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Circ Res. 2003 May 2;92(8):827-39 PMID: 12730128
  15. Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways.
    Oncogene. 2003 May 29;22(22):3371-85 PMID: 12776188
  16. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.
    Microbiol Mol Biol Rev. 2003 Jun;67(2):175-212, table of contents PMID: 12794189
  17. Tales from the crypt[ic] sites of the extracellular matrix.
    Trends Cell Biol. 2003 Jul;13(7):366-75 PMID: 12837607
  18. E-Cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells.
    Am J Pathol. 2003 Aug;163(2):653-61 PMID: 12875984
  19. Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein.
    J Virol. 2003 Sep;77(17):9346-58 PMID: 12915550
  20. Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells.
    J Virol. 2003 Sep;77(18):9738-49 PMID: 12941882
  21. Axis of evil: molecular mechanisms of cancer metastasis.
    Oncogene. 2003 Sep 29;22(42):6524-36 PMID: 14528277
  22. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice.
    Nat Genet. 2003 Nov;35(3):252-7 PMID: 14517555
  23. Preliminary communication: matrix metalloproteinases in Kaposi's sarcoma.
    Br J Dermatol. 2003 Oct;149(4):905-7 PMID: 14616400
  24. Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection.
    Cancer Res. 2004 Jan 1;64(1):72-84 PMID: 14729610
  25. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells.
    Acta Histochem. 1999 Jul;101(3):305-16 PMID: 10443293
  26. AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): a model of the interplay of the immune system, virus, and cancer. "On the offensive--the Trojan Horse is being destroyed"--Part A: Kaposi's sarcoma.
    Cancer Invest. 2004;22(5):774-86 PMID: 15581058
  27. The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.
    Science. 2005 Feb 4;307(5710):739-41 PMID: 15692053
  28. Metalloproteinases and their inhibitors in tumor angiogenesis.
    Int J Cancer. 2005 Jul 20;115(6):849-60 PMID: 15729716
  29. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability.
    Nature. 2005 Jul 7;436(7047):123-7 PMID: 16001073
  30. Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells.
    Virology. 2005 Dec 5;343(1):47-64 PMID: 16154170
  31. Platelet-activating factor induces matrix metalloproteinase-9 expression through Ca(2+)- or PI3K-dependent signaling pathway in a human vascular endothelial cell line.
    FEBS Lett. 2005 Nov 21;579(28):6451-8 PMID: 16288746
  32. Kaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways.
    J Virol. 2005 Dec;79(24):15027-37 PMID: 16306573
  33. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.
    Nat Rev Cancer. 2006 Mar;6(3):227-39 PMID: 16498445
  34. Identification and characterization of the Orf49 protein of Kaposi's sarcoma-associated herpesvirus.
    J Virol. 2006 Mar;80(6):3062-70 PMID: 16501115
  35. Matrix metalloproteinases and tumor metastasis.
    Cancer Metastasis Rev. 2006 Mar;25(1):9-34 PMID: 16680569
  36. Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection.
    J Virol. 2006 Jun;80(11):5371-82 PMID: 16699017
  37. Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1.
    J Virol. 2007 Apr;81(8):3980-91 PMID: 17287278
  38. Molecular biology of KSHV in relation to AIDS-associated oncogenesis.
    Cancer Treat Res. 2007;133:69-127 PMID: 17672038
  39. The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors.
    Cancer Res. 2004 Apr 15;64(8):2774-81 PMID: 15087393
  40. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.
    Science. 2000 Aug 18;289(5482):1202-6 PMID: 10947989
  41. Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor.
    Mol Biol Cell. 2001 Oct;12(10):2934-46 PMID: 11598182
  42. MMP inhibitors augment fibroblast adhesion through stabilization of focal adhesion contacts and up-regulation of cadherin function.
    J Biol Chem. 2001 Oct 26;276(43):40215-24 PMID: 11500488
  43. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study.
    J Clin Oncol. 2002 Jan 1;20(1):153-9 PMID: 11773164
  44. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis.
    Neoplasia. 2001 Nov-Dec;3(6):459-68 PMID: 11774028
  45. The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element.
    Blood. 2002 Jan 15;99(2):649-54 PMID: 11781250
  46. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells.
    Am J Pathol. 2002 Feb;160(2):673-80 PMID: 11839588
  47. Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells.
    Cell. 2002 Feb 8;108(3):407-19 PMID: 11853674
  48. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis.
    J Virol. 2002 Jun;76(12):6185-96 PMID: 12021352
  49. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
    Int J Cancer. 2002 May 10;99(2):157-66 PMID: 11979428
  50. Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway.
    J Biol Chem. 2002 Nov 15;277(46):43830-5 PMID: 12235151
  51. Matrix metalloproteinases as modulators of inflammation and innate immunity.
    Nat Rev Immunol. 2004 Aug;4(8):617-29 PMID: 15286728
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2007-07-00
Epub
2007-00-18
Pages
7001-10
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC1933284
Subset
IM
Grants
NCI NIH HHS · R01 CA096512 · United States
NCI NIH HHS · R01 CA124332 · United States
NIDCR NIH HHS · DE017333 · United States
NCI NIH HHS · CA096512 · United States
NIDCR NIH HHS · R01 DE017333 · United States
NCI NIH HHS · CA124332 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com